Article: Hepatocarcinogenesis by peroxisome proliferators.
The Journal of toxicological sciences
2004 Volume 29, Issue 1, Page(s) 1–12
Abstract: ... the involvement of HGF in hepatocarcinogenesis caused by peroxisome proliferators. After male F-344 rats were ... since many of hypolipidemic peroxisome proliferators induce hepatocellular carcinomas in both rats and mice, the relationship ... by peroxisome proliferators but not by genotoxic carcinogenesis, and that those changes play an important role ...
| Abstract | It is well known that various kinds of hypolipidemic drugs induce marked changes in the livers of rats and mice. The initial hepatic responses in rodents are marked hepatomegaly, proliferation of peroxisomes in association with changes in peroxisome structure and enzyme composition. Furthermore, since many of hypolipidemic peroxisome proliferators induce hepatocellular carcinomas in both rats and mice, the relationship between peroxisome proliferation and hepatocarcinogenicity of these drugs has become extremely important. However, it has not yet been established whether there are any direct relationships among pharmacological action, peroxisome proliferation and carcinogenicity of these drugs. In order to clarify this task, we have studied the involvement of HGF in hepatocarcinogenesis caused by peroxisome proliferators. After male F-344 rats were orally given Wy-14,643, hepatocarcinomas and (pre) neoplastic nodules were observed in the livers. At that time, the content of HGF and the expression of HGF mRNA were significantly decreased in the liver tumors. These findings may indicate that decreases in hepatic HGF levels are specific events induced by peroxisome proliferators but not by genotoxic carcinogenesis, and that those changes play an important role in the promotion of neoplastic or preneoplastic cell growth induced by peroxisome proliferators. Decrease in HGF induced by peroxisome proliferators such as Wy-14,643 would inhibit the growth of normal hepatocytes and then lend an advantageous circumstance for the selective growth of neoplastic or preneoplastic cells, resulting in the development of growth of tumors. |
|---|---|
| MeSH term(s) | Administration, Oral ; Animals ; Gene Expression Regulation, Neoplastic ; Hepatocyte Growth Factor/genetics ; Hepatocyte Growth Factor/metabolism ; Liver/drug effects ; Liver/metabolism ; Liver Neoplasms, Experimental/chemically induced ; Liver Neoplasms, Experimental/metabolism ; Liver Neoplasms, Experimental/pathology ; Male ; Peroxisome Proliferators/administration & dosage ; Peroxisome Proliferators/chemistry ; Peroxisome Proliferators/toxicity ; Precancerous Conditions/chemically induced ; Precancerous Conditions/pathology ; Pyrimidines/toxicity ; RNA, Messenger/metabolism ; Rats ; Rats, Inbred F344 |
| Chemical Substances | Peroxisome Proliferators ; Pyrimidines ; RNA, Messenger ; Hepatocyte Growth Factor (67256-21-7) ; pirinixic acid (86C4MRT55A) |
| Language | English |
| Publishing date | 2004-02 |
| Publishing country | Japan |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
| ZDB-ID | 770623-6 |
| ISSN | 1880-3989 ; 0388-1350 |
| ISSN (online) | 1880-3989 |
| ISSN | 0388-1350 |
| DOI | 10.2131/jts.29.1 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1682: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.